|
Year |
Place |
Speaker |
Title |
|
2020 |
Virtual meeting |
Prof E Van Schaftingen |
Elucidating the causes of metabolic disorders: the new veins to explore |
|
2019 |
Rotterdam |
Dr C Vianey-Saban |
From fatty acid oxidation to riboflavin Make metabolites great again |
|
2018 |
Athens |
Prof P T Clayton |
Restoring missing metabolites: from bile to acid to B6 |
|
2016 |
Rome |
Prof M Zeviani |
Mitochondrial Disorders, a journey through the magic circle and beyond |
|
2015 |
Lyon |
Prof B T Poll-The |
Peroxisomal disorders and more…: Why I have not stopped examining patients |
|
2014 |
Innsbruck |
Prof G Brown |
A wide circle around lactic acid |
|
2013 |
Barcelona |
Dr C Dionisi-Vici |
The daily challenge of understanding and treating metabolic disorders in children |
|
2012 |
Birmingham |
Prof R J A Wanders |
Inborn errors of metabolism including peroxisomal diseases in a changing world of omics and systems biology |
|
2011 |
Geneva |
Dr M T Vanier |
Lysosomal neurolipidoses: the enigmas and the challenges |
|
2010 |
Istanbul |
Prof B Wilcken |
Newborn Screening: How are we travelling? Where we might get to? |
|
2008 |
Lisbon |
Prof N Gregersen |
Mitochondrial fatty acid oxidation defects, remaining challenges |
|
2007 |
Hamburg |
Prof W S Sly |
Evolution of therapy for lysosomal diseases |
|
2005 |
Paris |
Prof J Leonard |
The treatment of inborn errors of metabolism |
|
2004 |
Amsterdam |
Prof M Gibson |
Gamma-hydroxybutyric aciduria: a biochemist’s education from a heritable disorder of GABA metabolism |
|
2002 |
Dublin |
Prof J Jaeken |
Congenital disorders of glycosylation: its all in it |
|
2001 |
Prague |
Prof H Galjaard |
New names for old disciplines |
|
1999 |
Genova |
Prof J M Saudubray |
Genetic hypoglycaemia |
|
1998 |
York |
Prof D Valle |
Ornithine metabolism, metabolic network and normal biology |
|
1997 |
Gothenburg |
Prof S J Segal |
Galactosaemia today: the enigma and the challenge |
|
1996 |
Cardiff |
Dr A M Spiegel |
Inborn errors of signal transduction mutations in G Protein-coupled receptors as a cause of disease |
|
1995 |
Toledo |
Dr G Salem |
Abnormal cholesterol biosynthesis in sitosterolaemia and the Smith-Lemli-Opitz syndrome |
|
1994 |
Edinburgh |
Prof H W Moser |
Adrenoleukodystrophy, natural history, treatment and outcome |
|
1993 |
Manchester |
Prof J P Kraus |
Molecular basis of phenotype expression in homocystinuria |
Komrower Commemorative Lectures
Komrower Commemorative Lectures
KOMROWER COMMEMORATIVE LECTURES
| Year | Place | Speaker | Title |
| 2021 | |||
| 2020 | Virtual Meeting | Prof E Van Schaftingen | Elucidating the causes of metablic disorders: the new veins to explore |
| 2019 | Rotterdam | Dr C Vianey-Saban |
From fatty acid oxidation to riboflavin |
| 2018 | Athens | Prof P T Clayton | Restoring missing metabolites: from bile acid to B6 |
| 2016 | Rome | Prof M Zeviani | Mitochondrial Disorders, a journey through the magic circle and beyond |
| 2015 | Lyon | Prof B T Poll-The | Peroxisomal disorders and more…: Why I have not stopped examining patients |
| 2014 | Innsbruck | Prof G Brown | A wide circle around lactic acid |
| 2013 | Barcelona | Dr C Dionisi-Vici | The daily challenge of understanding and treating metabolic disorders in children |
| 2012 | Birmingham | Prof R J A Wanders | Inborn errors of metabolism including peroxisomal diseases in a changing world of omics and systems biology |
| 2011 | Geneva | Dr M T Vanier | Lysosomal neurolipidoses: the enigmas and the challenges |
| 2010 | Istanbul | Prof B Wilcken | Newborn Screening: How are we travelling? Where we might get to? |
| 2008 | Lisbon | Prof N Gregersen | Mitochondrial fatty acid oxidation defects, remaining challenges |
| 2007 | Hamburg | Prof W S Sly | Evolution of therapy for lysosomal diseases |
| 2005 | Paris | Prof J Leonard | The treatment of inborn errors of metabolism |
| 2004 | Amsterdam | Prof M Gibson | Gamma-hydroxybutyric aciduria: a biochemist’s education from a heritable disorder of GABA metabolism |
| 2002 | Dublin | Prof J Jaeken | Congenital disorders of glycosylation: its all in it |
| 2001 | Prague | Prof H Galjaard | New names for old disciplines |
| 1999 | Genova | Prof M Saudubray | Genetic hypoglycaemia |
| 1998 | York | Prof D Valle | Ornithine metabolism, metabolic network and normal biology |
| 1997 | Gothenburg | Prof S J Segal | Galactosaemia today: the enigma and the challenge |
| 1996 | Cardiff | Dr A M Spiegel | Inborn errors of signal transduction mutations in G Protein-coupled receptors as a cause of disease |
| 1995 | Toledo | Dr G Salem | Abnormal cholesterol biosynthesis in sitosterolaemia and the Smith-Lemli-Opitz syndrome |
| 1994 | Edinburgh | Prof H W Moser | Adrenoleukodystrophy, natural history, treatment and outcome |
| 1993 | Manchester | Prof J P Kraus | Molecular basis of phenotype expression in homocystinuria |
Guidelines Development Support
SSIEM announces as a new initiative the support for guideline development.
SSIEM members interested in this should follow the application process in the attached form.
Please submit the completed form at any time to the Honorary Secretary SSIEM. Your proposal will be evaluated by a committee from SSIEM Council members. The final decision will be made at the next forthcoming Council meeting (these meetings are held each in March, July, September, and December) and thereafter communicated to you.
Contact SSIEM Honorary Secretary
2020
Approved 23 March
Ute Spiekerkötter
Consensus Guideline for the diagnosis and management of long-chain fatty acid oxidation defects
€ 20,000.00
2019
Approved 3 September
Patrick Forny & Matthias Baumgartner
Update MMA/PA Guidelines
€ 10,000.00
Approved 6 July
Samuel Gröschel
European Reference Network for Rare Neurological Disorders task force to develop a guideline for Metachromatic Leukodystrophy. MDL Guideline
€ 20,000.00
Symposium Travel Scholarship Application
OPENING DATE
Applications will be accepted between 02 Feb 2019 and 30-Mar-2019 (Midnight GMT)
Symposium Travel Scholarship Application
Please read requirements shown below and ensure you have all the documents ready before proceeding
Previous Awardees
 |
2019 Prof Dr Med Johannes Haberle Zurich Switzerland The impact of ammonia levels and dialysis on outcome in 202 patients with neonatal onset urea cycle disorders Download Publication Additional Information Epub 2018 Mar 8; 2018 Jul;41(4):689-698. doi: 10.1007/s10545-018-0157-4 |
 |
2018 Ass Prof Melanie Gillingham Portland USA Triheptanoin versus trioctanoin for long-chain fatty acid oxidation disorders: a double blinded randomized controlled trial Download Publication Additional Information J Inherit Metab Dis. 2017; 40:831–843 |
 |
2017 Dr Terry Derks Groningen The Netherlands Glycogen storage disease type III: diagnosis, genotype, management, clinical course and outcome. Download Publication Additional Information J Inherit Metab Dis. 2016; 39:697-704 |
 |
2016 Prof Shamima Rahman London United Kingdom Paediatric single mitochondrial DNA deletion disorders: an overlapping spectrum of disease. Download Publication Additional Information J Inherit Metab Dis. 2015; 38:445-457 |
 |
2015 Dr Yannis Trakadis Montreal Canada Update on transcobalamin deficiency: clinical presentation, treatment and outcome Download Publication Additional Information J Inherit Metab Dis. 2014; 37:461-473 |
 |
2014 Dr F Sedel Paris France Krabbe disease in adults: phenotypic and genotypic update from a series of 11 cases and a review. Download Publication Additional Information J Inherit Metab Dis. 2013;36:859-68 |
 |
2013 Dr SE Waisbren Boston USA The adult galactosemic phenotype. Download Publication Additional Information J Inherit Metab Dis. 2012;35:279-86 |
 |
2012 Dr M del Socorro Perez Poyato Barcelona Spain Juvenile neuronal ceroid lipofuscinosis: clinical course and genetic studies in Spanish patients. Download Publication Additional Information J Inherit Metab Dis. 2011;34:1083-93 |
 |
2011 Prof Dr F A Wijburg Amsterdam The Netherlands Mucopolysaccharidosis type IIIB may predominantly present with an attenuated clinical phenotype. Download Publication Additional Information J Inherit Metab Dis. 2010;33:759–67 |
 |
2010 Dr Friederike H�rster Heidelberg Germany Prediction of outcome in isolated methylmalonic acidurias: combined use of clinical and biochemical parameters Download Publication |
 |
2009 Prof Dr Ute Spiekerkoetter Dusseldorf Germany Management and outcome in 75 individuals with long-chain fatty acid oxidation defects:results from a workshop Download Publication |